Design of cyclic and linear peptide antagonists of vasopressin and oxytocin: current status and future directions.
Manning
M
M
Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699-0008.
Chan
W Y
WY
Sawyer
W H
WH
D000595:Amino Acid Sequence; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors*; D015195:Drug Design; D005544:Forecasting; D006801:Humans; D008969:Molecular Sequence Data; D010121:Oxytocin / Q000037:antagonists & inhibitors*; D010455:Peptides / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000494:pharmacology*
D065092:Antidiuretic Hormone Receptor Antagonists; D010455:Peptides; D010456:Peptides, Cyclic; D001127:Arginine Vasopressin; D010121:Oxytocin